Technology overview

Zolidd® is a proprietary bioactive nanolayer with a bone-strengthening drug. With Zolidd® on an implant, the bone grows stronger, stability increases, and the risk of complications is reduced. When the implant with Zolidd® on is inserted into bone, the drug is made available to the bone surrounding the implant.

The Zolidd® Nanolayer

Zolidd® is a thin layer of a blood protein, and fully biocompatible. Any implant can be prepared with Zolidd®. Zolidd® will improve the bone holding power without affecting the underlying properties of the implant itself, and using it requiers no changes in the surgical procedures.

Bisphosphonate drugs

The drug used in Zolidd® is a bisphosphonate. Bisphosphonates are bone-strengthening drugs, and the most prescribed class of drugs for patients with weak bone. Bisphosphonates affect the bone metabolism locally, and when an implant with Zolidd® is placed in the bone, the effect of the drug will be on the bone surrounding the implant.